LOG IN
SIGN UP
MARKET
APDN
APDN
Applied Dna Scie
NASDAQ
Real-time Quotes | Nasdaq Last Sale
1.230
+0.050
+4.24%
After Hours: 1.200 -0.03 -2.44% 18:00 05/27 EDT
OPEN
1.241
PREV CLOSE
1.180
HIGH
1.247
LOW
1.190
VOLUME
21.67K
TURNOVER
0
52 WEEK HIGH
8.10
52 WEEK LOW
1.082
MARKET CAP
10.13M
P/E (TTM)
-0.6391
1D
5D
1M
3M
1Y
5Y
--HC Wainwright Adjusts Applied DNA Sciences' Price Target to $4 from $6, Keeps Buy Rating
MT Newswires · 05/16 09:12
Recap: Applied DNA Sciences Q2 Earnings
Applied DNA Sciences (NASDAQ:APDN) reported its Q2 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Benzinga · 05/12 22:36
Applied DNA Sciences (APDN) Reports Q2 Loss, Tops Revenue Estimates
Applied DNA Sciences (APDN) delivered earnings and revenue surprises of 6.67% and 32.19%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/12 22:25
Applied DNA Sciences Q2 Sales $6.10M Beat $4.50M Estimate
Applied DNA Sciences (NASDAQ:APDN) reported quarterly sales of $6.10 million which beat the analyst consensus estimate of $4.50 million by 35.56 percent. This is a 128.29 percent increase over sales of $2.67 million the
Benzinga · 05/12 20:12
Applied DNA Sciences GAAP EPS of -$0.23 beats by $0.10, revenue of $6.15M beats by $1.65M
Applied DNA Sciences press release (NASDAQ:APDN): Q1 GAAP EPS of -$0.23 beats by $0.10. Revenue of $6.15M (+130.3% Y/Y) beats by $1.65M. Cash at $6.5 Million Inclusive of Net Proceeds
Seekingalpha · 05/12 20:09
-- Earnings Flash (APDN) APPLIED DNA SCIENCES Posts Q2 Revenue $6.1M, vs. Street Est of $4.5M
MT Newswires · 05/12 16:24
Earnings Outlook For Applied DNA Sciences
Applied DNA Sciences (NASDAQ:APDN) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that Applied DNA Sciences will report an earnings per share (EPS) ...
Benzinga · 05/11 17:02
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Benzinga · 05/11 16:28
No Data
Learn about the latest financial forecast of APDN. Analyze the recent business situations of Applied Dna Scie through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating
Based on 3 analysts
Buy
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.
0.00%Strong Buy
100.00%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average APDN stock price target is 11.33 with a high estimate of 24.00 and a low estimate of 4.000.
Current 1.230
EPS
Actual
Estimate
-0.50-0.38-0.25-0.13
Institutional Holdings
Institutions: 47
Institutional Holdings: 1.69M
% Owned: 20.55%
Shares Outstanding: 8.23M
TypeInstitutionsShares
Increased
4
38.30K
New
4
524.66K
Decreased
7
90.80K
Sold Out
6
47.61K
- Performance
- Asset Allocation
- Dividend History
No Data
Industry
Specialty Chemicals
+1.73%
Chemicals
+2.41%
Key Executives
Chairman/President/Chief Executive Officer/Director
James Hayward
Chief Financial Officer
Beth Jantzen
Chief Operating Officer
Judith Murrah
Other
Clay Shorrock
Independent Director
Scott Anchin
Independent Director
John Bitzer
Independent Director
Robert Catell
Independent Director
Joseph Ceccoli
Independent Director
Elizabeth Ferguson
Independent Director
Yacov Shamash
Independent Director
Sanford Simon
No Data
No Data
About APDN
Applied DNA Sciences, Inc. (Applied DNA) develops and markets DNA-based technology solutions. The Applied DNA provides preclinical contract research and manufacturing services for the nucleic acid-based therapeutic markets. Applied DNA is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). The Applied DNA products include: Signature Molecular Tags, SigNify, and CertainT. SigNature Molecular Tags provides forensic power and protection for a range of applications. SigNify IF portable DNA readers and SigNify consumable reagent test kits provide real-time authentication of molecular tags in the field and front-line solution for supply chain integrity backed with forensic-level molecular tag authentication. CertainT includes tagging, testing and tracking platforms and solutions, enabling manufacturers, and trade organizations to convey proof of their product claims.
Webull offers kinds of Applied DNA Sciences Inc stock information, including NASDAQ:APDN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APDN stock news, and many more online research tools to help you make informed decisions.
You can practice and explore trading APDN stock methods without spending real money on the virtual paper trading platform.